Building Stronger Manufacturing Relationships

Avara Liscate is a sterile injectable manufacturing facility producing liquid and lyophilized parenterals in vials and ampoules. The facility served a vital role in the production of critical care treatments during the COVID-19 pandemic. In this video, Andrea Baiocchi, Liscate’s Site Director, and Marco Scanziani, Customer Relationship Leader, discuss how the Liscate facility was able to overcome the challenges presented by the pandemic by playing to Avara’s existing strengths: experience, flexibility, and adaptability. Because our teams recognize that producing quality products is the number one priority, we foster strong relationships with our clients in order to quickly and efficiently deliver lifesaving drugs to patients worldwide

Avara Pharmaceutical Services, Inc.

Avara is a contract manufacturing organization whose operations are built around the priorities and objectives of our clients. Our network of facilities offers manufacturing and packaging of drug product in oral solid dosage forms and liquid/lyophilized steriles. Our flexible and tailored approach enables us to support companies of all sizes.

https://www.avara.com/
Previous
Previous

AIAC and AVARA Pharmaceuticals co-sponsor luncheon honoring the Prime Minister of Japan

Next
Next

Avara Board Announces Changes to Executive Team